Trials / Active Not Recruiting
Active Not RecruitingNCT05725304
The Registry of Genetic Expression of Taiwan Urologic Cancer
National Health Research Institutes,Taiwan
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- National Health Research Institutes, Taiwan · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This project is a nationwide precision medicine program for urothelial carcinoma and renal cell carcinoma.
Detailed description
This project providing free and immediate next-generation gene sequencing testing for patients with urothelial and renal cell carcinomas that have is diagnosed or that have previously received systemic therapy. The goal of this project is to assist participating institutions in integrating next-generation sequencing results and building a real-time data storage and sharing platform, as well as establishing a tumor molecular biological atlas of Taiwanese patients with urothelial carcinoma and renal cell carcinoma. The data will be linked with clinical prognosis to facilitate the rapid screening of patients for effective potential therapeutic drugs and clinical trials, which is anticipated to prolong the survival rate of patients.
Conditions
Timeline
- Start date
- 2023-01-07
- Primary completion
- 2029-10-29
- Completion
- 2029-10-29
- First posted
- 2023-02-13
- Last updated
- 2025-05-22
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT05725304. Inclusion in this directory is not an endorsement.